Patent · US Active

HPLC method for the analysis of bosetan and related substances and use of these substances as reference standards and markers

US8975402B2 · kind B2 · utility

0Cited by
5References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 2, 2009
Grant dateMar 10, 2015
Priority date
Expiry dateMar 4, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D239/52
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to a new HPLC method for the analysis of the drug substance bosentan and related substances and to the use of said substances as reference standards and markers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.